Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

In an effort to better serve our users, we have streamlined our content offering. As a result, we no longer publish new content or update existing content in Renal Cell Carcinoma. Visit the 'Content & Subscriptions' tab of your Settings page at any time to update your Dashboard or Newsletter Subscription preferences to continue to see news and information that interests you most.

featured
Published in Renal Cell Carcinoma

Expert Opinion / Cases · September 03, 2018

Mixed Response on Nivo, Should We Switch?

 JoAnn Hsu
Written by

 

Discuss This item Follow

No comments yet, be the first to start the discussion!

  • Eman Ahmed

    Sep 11, 2018

    If there is general improvement of his clinical status with good tolerance to treatment, so better to continue on nivo for another two month then repeat images again if it shows further disease progression so at that time we can switch  

  • john locke

    Sep 22, 2018

    leave him on nivo

  • Dec 23, 2024

    Pending Moderator approval.
    Delete

Further Reading